Vetter's V-OVS® next Syringe Closure Wins Red Dot Design Concept Award
Key Points
- Vetter received a Red Dot Award in the Design Concept category for V-OVS® next, its next-generation syringe closure system building on more than 20 years of syringe closure development.
- The system features a locking mechanism to help prevent unintended rotation between syringe and closure, plus a tamper-evident seal that breaks irreversibly on first opening.
- Ergonomic gripping elements and visual opening indicators aim for more intuitive handling, giving pharma and biotech companies another option for differentiating drug delivery products.
CDMO Vetter has received a Red Dot Award in the Design Concept category for V-OVS® next, its next-generation syringe closure system designed to improve handling, product security, and the user experience. The award recognizes the design of the closure system, which builds on more than 20 years of development and market experience with Vetter’s syringe closure technology. The company developed the latest iteration to address evolving requirements in pharmaceutical and biotechnology applications, including biologics and drug products designed with end users in mind.
V-OVS® next incorporates a locking mechanism intended to help prevent unintended rotation between the syringe and its closure. The system also features a tamper-evident seal that breaks irreversibly when first opened, providing a visible indication that the closure has been accessed. Ergonomic gripping elements and visual opening indicators are additional features intended to make the system easier to handle. According to Vetter, the design combines functional improvements with a refined appearance, offering pharmaceutical and biotechnology companies another option for differentiating their drug delivery products.
“Throughout development, we focused on creating a closure system that enhances functionality and patient safety, while delivering a more intuitive handling experience,” says Dr. Claus Feussner, Senior Vice President Development Service at Vetter. He adds that the award reflects the importance of integrating technical requirements and human factors into pharmaceutical packaging design.
The recognition comes as drug developers face increasingly complex requirements for packaging and delivery systems, particularly for therapies that demand careful consideration of product integrity, handling, and usability. For syringe-based products, closure design can play a role in supporting secure connections and providing users with clear visual cues during opening.
For more information, visit www.vetter-pharma.com.
Total Page Views: 9
